Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With Hyperkalaemia
Status:
Suspended
Trial end date:
2022-07-31
Target enrollment:
Participant gender:
Summary
Prescribing Sodium zirconium cyclosilicate (SZC) with enhanced nutritional advice to
participants with hyperkalaemia on haemodialysis will reduce serum K+ (S-K+ ) and enable the
consumption of more fruit and vegetables and more satisfying diet. The study aims to show
that participants using SZC achieve S-K+ reduction as well as participants on SoC (other than
K+ binders), without the need for restricting K+ in the diet.